Deal overview
| Target | SHANGHAI RAAS BLOOD PRODUCTS CO LTD |
|---|---|
| Bidder | HAIER GROUP CORPORATION |
| Price | £80.00 Full version or £25.00 Light version |
| Publication Date | Dec 29, 2023 |
| Abstract | On 29 December 2023, Grifols SA ("Grifols"), a quoted Spanish producer of plasma-derived medicines, announced that it had agreed to sell a 20% stake in the quoted Chinese plasma derivatives company Shanghai RAAS Blood Products Co Ltd ("Shanghai RAAS") to the Chinese conglomerate Haier Group Corporation ("Haier Group"), for RMB 12.5 billion, or RMB 9.405 per share. Grifols ... |
| Number of pages (Full version) | 8 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
